Kevin  Gray  to  Substance-Related Disorders
                            
                            
                                This is a "connection" page, showing publications  Kevin  Gray  has written about  Substance-Related Disorders.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            3.826
         
        
        
     
 
    
        
        - 
            Cannabis Use Disorder in Adolescents. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):13-20.
            
            
                Score: 0.421
             
- 
            Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies. Curr Psychiatry Rep. 2019 09 14; 21(10):96.
            
            
                Score: 0.339
             
- 
            Youth Substance Use: Introduction to the Journal of Child and Adolescent Psychopharmacology Special Issue. J Child Adolesc Psychopharmacol. 2019 08; 29(7):475-476.
            
            
                Score: 0.337
             
- 
            Pharmacological Treatment of Youth Substance Use Disorders. J Child Adolesc Psychopharmacol. 2019 08; 29(7):559-572.
            
            
                Score: 0.330
             
- 
            Methods to reduce the incidence of false negative trial results in substance use treatment research. Curr Opin Psychol. 2019 12; 30:35-41.
            
            
                Score: 0.325
             
- 
            Research Review: What have we learned about adolescent substance use? J Child Psychol Psychiatry. 2018 06; 59(6):618-627.
            
            
                Score: 0.292
             
- 
            Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review. Am J Addict. 2017 Mar; 26(2):99-111.
            
            
                Score: 0.283
             
- 
            Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review. Drug Alcohol Depend. 2016 Oct 01; 167:1-7.
            
            
                Score: 0.273
             
- 
            Alcohol and Drug Use and the Developing Brain. Curr Psychiatry Rep. 2016 May; 18(5):46.
            
            
                Score: 0.269
             
- 
            Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106.
            
            
                Score: 0.230
             
- 
            Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug Alcohol Depend. 2011 Sep 01; 117(2-3):242-7.
            
            
                Score: 0.188
             
- 
            Advances in diagnosis of adolescent substance abuse. Adolesc Med Clin. 2006 Jun; 17(2):411-25.
            
            
                Score: 0.135
             
- 
            The estimand framework and its application in substance use disorder clinical trials: a case study. Am J Drug Alcohol Abuse. 2021 11 02; 47(6):658-663.
            
            
                Score: 0.098
             
- 
            Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) study. Drug Alcohol Depend. 2021 10 01; 227:108946.
            
            
                Score: 0.097
             
- 
            Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women. Drug Alcohol Depend. 2021 01 01; 218:108383.
            
            
                Score: 0.092
             
- 
            A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
            
            
                Score: 0.070
             
- 
            Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav. 2011 Aug; 99(2):285-94.
            
            
                Score: 0.047